Loading clinical trials...

Cognitive Impairment Characteristics and Biological Mechanisms in Untreated Severe Mental Illness | Clinical Trials | Clareo Health

Back to clinical trial search

Enrolling By InvitationNCT07448675

Cognitive Impairment Characteristics and Biological Mechanisms in Untreated Severe Mental Illness

Patients with Severe Mental Illness (SMI) frequently exhibit cognitive impairment of varying degrees, involving multiple cognitive domains. These domains include working memory, attention/vigilance, v...

Lead sponsor: Tianjin Anding Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Trial snapshot

StatusENROLLING_BY_INVITATION

Phase—

Enrollment230

Start dateFeb 2023

Last updatedMar 4, 2026

Condition

Patients With Severe Mental Illness

Locations shown

Tianjin Anding Hospital

Tianjin

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 4, 2026Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions